P. Owiafe

发表

Immunogenic Mycobacterium africanum Strains Associated with Ongoing Transmission in The Gambia

B. D. de Jong, M. Antonio, T. Corrah, 2013, Emerging infectious diseases.

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study

M. Antonio, M. Alderson, D. Borys, 2015, Human vaccines & immunotherapeutics.

Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis

M. Ota, O. Adewole, D. Obaseki, 2013, Nigerian medical journal : journal of the Nigeria Medical Association.

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.

R. Adegbola, H. McShane, A. Hill, 2006, The Lancet. Infectious diseases.

Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults

M. Ota, S. Donkor, O. Owolabi, 2016, Tuberculosis.

Mycobacterium tuberculosis Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to Tobacco.

P. Hill, M. Ota, S. Donkor, 2017, The American journal of tropical medicine and hygiene.

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.

S. Schoonbroodt, B. Greenwood, M. Antonio, 2017, Vaccine.

Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial.

P. Aka, R. Adegbola, I. Adetifa, 2013, American journal of respiratory and critical care medicine.

Viral Hepatitis Endemicity and Trends among an Asymptomatic Adult Population in Ho: A 5-Year Retrospective Study at the Ho Municipal Hospital, Ghana

J. Osei-Yeboah, G. Norgbe, S. Lokpo, 2017, Hepatitis research and treatment.

The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo.

R. Adegbola, H. McShane, P. Hill, 2007, Vaccine.

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

A. Simon, R. Adegbola, H. McShane, 2008, PloS one.

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

R. Adegbola, H. McShane, A. Hill, 2011, PLoS ONE.

Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

R. Adegbola, H. McShane, A. Hill, 2008, PloS one.

Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic Setting

I. Adetifa, C. Bottomley, S. Donkor, 2014, PloS one.

Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.

B. Greenwood, M. Antonio, M. Ota, 2019, Vaccine.

Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia.

R. Adegbola, K. McAdam, D. Jeffries, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis

T. Ottenhoff, Alimuddin Zumla, G. Rook, 2006, Clinical and Vaccine Immunology.

Haematological and biochemical reference values of Gambian infants

I. Baldeh, M. Ota, S. Donkor, 2014, Tropical medicine & international health : TM & IH.

Increased expression of mRNA encoding interleukin (IL)‐4 and its splice variant IL‐4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation

Alimuddin Zumla, G. Rook, D. Jeffries, 2004, Immunology.

ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease.

K. McAdam, D. Jeffries, P. Hill, 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Seroepidemiology of Hepatitis B and C Virus Infections: A Five-Year Retrospective Study among Blood Donors in Saboba District in the Northern Region of Ghana

D. Adedia, P. Owiafe, P. K. Kwadzokpui, 2021, BioMed research international.

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.

H. McShane, M. Ota, O. Owolabi, 2012, Vaccine.

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

S. Rowland-Jones, R. Adegbola, H. McShane, 2011, Science Translational Medicine.

Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model.

R. Adegbola, K. McAdam, D. Jeffries, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and Morphological Types of Anaemia among Children Under-Five Years in the Volta Regional Hospital of Ghana

Joseph Adu-Amankwaah, P. Owiafe, Innocent Afeke, 2018 .

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.

M. Demoitié, E. Jongert, O. Ofori-Anyinam, 2014, Tuberculosis.

Differential Cytokine Levels in Adults Induced by a Novel Candidate TB Boost Vaccine, MVA85A-According to Previous BCG Vaccination Status

H. McShane, P. Hill, M. Ota, 2012 .

Diagnostic utility of QuantiFERON-TB gold in-tube in active pulmonary Tuberculosis in Nigeria.

M. Ota, O. Adewole, A. Onipede, 2013, West African journal of medicine.

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants

S. Rowland-Jones, R. Adegbola, H. McShane, 2011, Science Translational Medicine.

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.

S. Schoonbroodt, B. Greenwood, M. Antonio, 2017, Vaccine.